Clinical trials
Phase 2 Multiple Myeloma trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| Austrian Forum Against Cancer | 2 |
| Sanofi | 2 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| Cellectar Biosciences, Inc. | 1 |
| European Myeloma Network B.V. | 1 |
| Gilead Sciences | 1 |
| Janssen-Cilag International NV | 1 |
| Oncopeptides AB | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 17 |
| Recurrence | 2 |
| Renal Insufficiency | 2 |
| Blood Protein Disorders | 1 |
| Bone Marrow Neoplasms | 1 |
| Disease | 1 |
| Hematologic Diseases | 1 |
| Immunoproliferative Disorders | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.